New tech shows promise for ‘engineering’ cells to prevent type 1 diabetes
Researchers at UChicago have developed a nanoparticle system that can effectively deliver mRNA to insulin-producing cells, protecting them from the body’s autoimmune response
Albert Bendelac, renowned UChicago pathologist and mentor, 1956-2023
Professor helped establish Committee on Immunology as home of important research, premiere training program for young scientists
Human insulin as safe and effective as costlier insulin analogs
<p>Prof. Elbert S. Huang co-authors study comparing human insulin to insulin analog drugs</p>
Yale News
Two diabetes medications don’t slow progression of type 2 diabetes in youth
<p>RISE study, conducted in part at UChicago Medical Center, finds that tested diabetes medications do not slow the condition’s progression</p>
Could insulin pills prevent diabetes? Big study seeks answer
Article cites study co-authored by Prof. Louis Philipson on preventative diabetes treatments
Associated Press
Rare mutation kills off gene responsible for diabetes
Prof. Louis Philipson comments on significance of finding diabetes-reducing gene mutation for drug development
